No Data
No Data
Express News | Annexon Announces Phase 3 ANX005 Trial In Guillain-Barré Syndrome Met Primary Endpoint
Express News | Annexon Inc : JP Morgan Raises Target Price to $12 From $11
Annexon: Expects to Grant the Underwriters a 30-Day Option to Purchase Up to an Additional $18.750M of Shrs of Its Common Stk >ANNX
Annexon: Expects to Grant the Underwriters a 30-Day Option to Purchase Up to an Additional $18.750M of Shrs of Its Common Stk >ANNX
Express News | Annexon Inc - Commenced an Underwritten Public Offering of $125 Mln of Shares of Its Common Stock
Express News | Annexon Announces Proposed Public Offering of Common Stock
Endra NDRA Offering; Annexon ANNX Phase 3 Data
No Data